Lemonade, Inc. (NYSE:LMND) Director Maria Angelidis-Smith Purchases 15,042 Shares

Lemonade, Inc. (NYSE:LMND) Director Maria Angelidis-Smith bought 15,042 shares of the stock in a transaction on Wednesday, November 13th. The stock was purchased at an average cost of $33.23 per share, for a total transaction of $499,845.66. Following the acquisition, the director now owns 33,554 shares of the company’s stock, valued at $1,114,999.42. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Maria Angelidis-Smith also recently made the following trade(s):

• On Friday, November 8th, Maria Angelidis-Smith bought 18,512 shares of Lemonade stock. The stock was purchased at an average cost of $27.42 per share, for a total transaction of $507,599.04.

Lemonade Trading Down 0.9 %

NYSE LMND opened at $31.99 on Thursday. The stock’s 50 day moving average is $19.81 and its 200 day moving average is $18.39. Lemonade, Inc. has a 12 month low of $14.03 and a 12 month high of $34.95. The stock has a market cap of $2.28 billion, a PE ratio of -10.52 and a beta of 1.68.

Lemonade (NYSE:LMND) last posted its quarterly earnings results on Wednesday, October 30th. The company reported ($0.95) EPS for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.07. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. The company had revenue of $136.60 million for the quarter, compared to analysts’ expectations of $129.10 million. During the same period in the previous year, the firm earned ($0.88) EPS. The firm’s revenue was up 19.3% compared to the same quarter last year. On average, analysts forecast that Lemonade, Inc. will post -3.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Keefe, Bruyette & Woods downgraded Lemonade from a “market perform” rating to an “underperform” rating and raised their price objective for the stock from $18.00 to $21.00 in a research note on Thursday, November 7th. JMP Securities reaffirmed a “market outperform” rating and issued a $40.00 price objective on shares of Lemonade in a research note on Tuesday, October 15th. Piper Sandler raised their price objective on Lemonade from $18.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, November 1st. Finally, Jefferies Financial Group decreased their price objective on Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a research note on Wednesday, October 9th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $21.83.

Institutional Trading of Lemonade

Large investors have recently added to or reduced their stakes in the company. Axiom Advisory LLC increased its position in shares of Lemonade by 1.6% during the 3rd quarter. Axiom Advisory LLC now owns 54,400 shares of the company’s stock valued at $897,000 after purchasing an additional 850 shares during the last quarter. Blue Trust Inc. increased its position in shares of Lemonade by 220.0% during the 3rd quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock valued at $45,000 after purchasing an additional 1,879 shares during the last quarter. Van ECK Associates Corp increased its position in shares of Lemonade by 12.1% during the 2nd quarter. Van ECK Associates Corp now owns 17,774 shares of the company’s stock valued at $293,000 after purchasing an additional 1,915 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Lemonade by 9.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock valued at $404,000 after purchasing an additional 2,196 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of Lemonade by 9.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,194 shares of the company’s stock valued at $482,000 after purchasing an additional 2,582 shares during the last quarter. Institutional investors own 80.30% of the company’s stock.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.